- Home
- NTRP vs GTBP Comparison
NTRP vs GTBP Comparison
Compare NTRP & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRP
- GTBP
- Stock Information
- Founded
- NTRP 1985
- GTBP 1965
- Country
- NTRP United States
- GTBP United States
- Employees
- NTRP N/A
- GTBP N/A
- Industry
- NTRP
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- NTRP
- GTBP Health Care
- Exchange
- NTRP NYSE
- GTBP Nasdaq
- Market Cap
- NTRP 6.7M
- GTBP 5.6M
- IPO Year
- NTRP N/A
- GTBP N/A
- Fundamental
- Price
- NTRP $5.32
- GTBP $2.33
- Analyst Decision
- NTRP Hold
- GTBP Strong Buy
- Analyst Count
- NTRP 1
- GTBP 1
- Target Price
- NTRP $5.00
- GTBP $11.00
- AVG Volume (30 Days)
- NTRP 45.3K
- GTBP 30.4K
- Earning Date
- NTRP 04-15-2025
- GTBP 05-14-2025
- Dividend Yield
- NTRP N/A
- GTBP N/A
- EPS Growth
- NTRP N/A
- GTBP N/A
- EPS
- NTRP N/A
- GTBP N/A
- Revenue
- NTRP $623,664.00
- GTBP N/A
- Revenue This Year
- NTRP $354.28
- GTBP N/A
- Revenue Next Year
- NTRP $536.37
- GTBP N/A
- P/E Ratio
- NTRP N/A
- GTBP N/A
- Revenue Growth
- NTRP 186.93
- GTBP N/A
- 52 Week Low
- NTRP $1.39
- GTBP $1.72
- 52 Week High
- NTRP $8.50
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- NTRP 53.73
- GTBP 49.06
- Support Level
- NTRP $5.01
- GTBP $2.10
- Resistance Level
- NTRP $6.48
- GTBP $2.46
- Average True Range (ATR)
- NTRP 0.69
- GTBP 0.19
- MACD
- NTRP 0.11
- GTBP -0.01
- Stochastic Oscillator
- NTRP 54.55
- GTBP 51.00
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.